Pathogenesis of Pre-Diabetes

Thirty-two subjects with impaired fasting glucose (IFG) and 28 subjects with normal fasting glucose (NFG) ingested a labeled meal and 75 g glucose (oral glucose tolerance test) on separate occasions. Fasting glucose, insulin, and C-peptide were higher (P < 0.05) in subjects with IFG than in those with NFG, whereas endogenous glucose production (EGP) did not differ, indicating hepatic insulin resistance. EGP was promptly suppressed, and meal glucose appearance comparably increased following meal ingestion in both groups. In contrast, glucose disappearance (Rd) immediately after meal ingestion was lower (P < 0.001) in subjects with IFG/impaired glucose tolerance (IGT) and IFG/diabetes but did not differ in subjects with IFG/normal glucose tolerance (NGT) or NFG/NGT. Net insulin action (Si) and insulin-stimulated glucose disposal (Si*) were reduced (P < 0.001, ANOVA) in subjects with NFG/IGT, IFG/IGT, and IFG/diabetes but did not differ in subjects with NFG/NGT or IFG/NGT. Defective insulin secretion also contributed to lower postprandial Rd since disposition indexes were lower (P < 0.001, ANOVA) in subjects with NFG/IGT, IFG/IGT, and IFG/diabetes but did not differ in subjects with NFG/NGT and IFG/NGT. We conclude that postprandial hyperglycemia in individuals with early diabetes is due to lower rates of glucose disappearance rather than increased meal appearance or impaired suppression of EGP, regardless of their fasting glucose. In contrast, insulin secretion, action, and the pattern of postprandial turnover are essentially normal in individuals with isolated IFG.

[1]  R. Rizza,et al.  Postprandial hyperglycemia in patients with noninsulin-dependent diabetes mellitus. Role of hepatic and extrahepatic tissues. , 1986, The Journal of clinical investigation.

[2]  Claudio Cobelli,et al.  Minimal model estimation of glucose absorption and insulin sensitivity from oral test: validation with a tracer method. , 2004, American journal of physiology. Endocrinology and metabolism.

[3]  C. Cobelli,et al.  Effects of a change in the pattern of insulin delivery on carbohydrate tolerance in diabetic and nondiabetic humans in the presence of differing degrees of insulin resistance. , 1996, The Journal of clinical investigation.

[4]  C. Bogardus,et al.  Metabolic characteristics of individuals with impaired fasting glucose and/or impaired glucose tolerance. , 1999, Diabetes.

[5]  T. Jenssen,et al.  Contribution of Abnormal Muscle and Liver Glucose Metabolism to Postprandial Hyperglycemia in NIDDM , 1990, Diabetes.

[6]  R. Rizza,et al.  Comparison of the pattern of postprandial carbohydrate metabolism after ingestion of a glucose drink or a mixed meal. , 1989, The Journal of clinical endocrinology and metabolism.

[7]  M. Beylot,et al.  Determination of the 13C-labeling pattern of glucose by gas chromatography-mass spectrometry. , 1993, Analytical biochemistry.

[8]  J. Meigs,et al.  The natural history of progression from normal glucose tolerance to type 2 diabetes in the Baltimore Longitudinal Study of Aging. , 2003, Diabetes.

[9]  S E Kahn,et al.  The effect of insulin dose on the measurement of insulin sensitivity by the minimal model technique. Evidence for saturable insulin transport in humans. , 1996, The Journal of clinical investigation.

[10]  R. DeFronzo,et al.  The disposal of an oral glucose load in patients with non-insulin-dependent diabetes. , 1988, Metabolism: clinical and experimental.

[11]  M. Cnop,et al.  Beta-cell function is a major contributor to oral glucose tolerance in high-risk relatives of four ethnic groups in the U.S. , 2002, Diabetes.

[12]  D. Kelley,et al.  Impaired postprandial glucose utilization in non-insulin-dependent diabetes mellitus. , 1994, Metabolism: clinical and experimental.

[13]  R. Bergman,et al.  Physiologic evaluation of factors controlling glucose tolerance in man: measurement of insulin sensitivity and beta-cell glucose sensitivity from the response to intravenous glucose. , 1981, The Journal of clinical investigation.

[14]  R. Chow,et al.  Functional and spatial segregation of secretory vesicle pools according to vesicle age , 2003, Nature.

[15]  R. Rizza,et al.  Carbohydrate metabolism in non-insulin-dependent diabetes mellitus. , 1992, The New England journal of medicine.

[16]  E. Bartoli,et al.  The significance of impaired fasting glucose versus impaired glucose tolerance: importance of insulin secretion and resistance. , 2003, Diabetes care.

[17]  G. Rutter,et al.  Visualising insulin secretion. The Minkowski Lecture 2004 , 2004, Diabetologia.

[18]  L. Eliasson,et al.  A subset of 50 secretory granules in close contact with L-type Ca2+ channels accounts for first-phase insulin secretion in mouse beta-cells. , 2002, Diabetes.

[19]  C. Cobelli,et al.  Regulation of endogenous glucose production after a mixed meal in type 2 diabetes. , 2002, American journal of physiology. Endocrinology and metabolism.

[20]  N. Abumrad,et al.  Insulin, glucagon, and glucose as regulators of hepatic glucose uptake and production in vivo. , 1987, Diabetes/metabolism reviews.

[21]  L. Saccá,et al.  Differential roles of splanchnic and peripheral tissues in the pathogenesis of impaired glucose tolerance. , 1984, The Journal of clinical investigation.

[22]  E. Feskens,et al.  Glucose tolerance and mortality: comparison of WHO and American Diabetic Association diagnostic criteria , 1999, The Lancet.

[23]  D. Pereg,et al.  Normal fasting plasma glucose levels and type 2 diabetes in young men. , 2005, The New England journal of medicine.

[24]  C Cobelli,et al.  Insulin sensitivity from meal tolerance tests in normal subjects: a minimal model index. , 2000, The Journal of clinical endocrinology and metabolism.

[25]  S. Kahn,et al.  Impact of differences in fasting glucose and glucose tolerance on the hyperbolic relationship between insulin sensitivity and insulin responses. , 2006, Diabetes care.

[26]  Claudio Cobelli,et al.  Oral Glucose Tolerance Test Minimal Model Indexes of β-Cell Function and Insulin Sensitivity , 2001 .

[27]  Glucose tolerance and mortality: comparison of WHO and American Diabetes Association diagnostic criteria. The DECODE study group. European Diabetes Epidemiology Group. Diabetes Epidemiology: Collaborative analysis Of Diagnostic criteria in Europe. , 1999, Lancet.

[28]  L. Melton,et al.  Effects of Changing Diagnostic Criteria on the Risk of Developing Diabetes , 1998, Diabetes Care.

[29]  B V Howard,et al.  Impaired glucose tolerance as a disorder of insulin action. Longitudinal and cross-sectional studies in Pima Indians. , 1988, The New England journal of medicine.

[30]  Claudio Cobelli,et al.  Mechanisms of the age-associated deterioration in glucose tolerance: contribution of alterations in insulin secretion, action, and clearance. , 2003, Diabetes.

[31]  Jeppe Sturis,et al.  Estimation of Insulin Secretion Rates from C-Peptide Levels: Comparison of Individual and Standard Kinetic Parameters for C-Peptide Clearance , 1992, Diabetes.

[32]  Michael Stumvoll,et al.  Glucose allostasis. , 2003, Diabetes.

[33]  K.,et al.  Experimental validation of measurements of glucose turnover in nonsteady state. , 1978, The American journal of physiology.

[34]  Claudio Cobelli,et al.  Measurement of selective effect of insulin on glucose disposal from labeled glucose oral test minimal model. , 2005, American journal of physiology. Endocrinology and metabolism.

[35]  M. Cnop,et al.  - Cell Function Is a Major Contributor to Oral Glucose Tolerance in High-Risk Relatives of Four Ethnic Groups in the U . , 2002 .

[36]  R. Bergman,et al.  Quantification of the Relationship Between Insulin Sensitivity and β-Cell Function in Human Subjects: Evidence for a Hyperbolic Function , 1993, Diabetes.

[37]  M. Hanefeld,et al.  Insulin secretion and insulin sensitivity pattern is different in isolated impaired glucose tolerance and impaired fasting glucose: the risk factor in Impaired Glucose Tolerance for Atherosclerosis and Diabetes study. , 2003, Diabetes care.

[38]  Ralph B D'Agostino,et al.  Fasting and postchallenge glycemia and cardiovascular disease risk: the Framingham Offspring Study. , 2002, Diabetes care.

[39]  R N Bergman,et al.  Glucose effectiveness assessed under dynamic and steady state conditions. Comparability of uptake versus production components. , 1997, The Journal of clinical investigation.

[40]  B. Hansen,et al.  Hepatic glucose production and insulin sensitivity preceding diabetes in monkeys. , 1989, The American journal of physiology.

[41]  R. Rizza,et al.  Glucose-induced suppression of endogenous glucose production: dynamic response to differing glucose profiles. , 2003, American journal of physiology. Endocrinology and metabolism.

[42]  Claudio Cobelli,et al.  Insulin sensitivity by oral glucose minimal models: validation against clamp. , 2005, American journal of physiology. Endocrinology and metabolism.

[43]  R. DeFronzo,et al.  Regulation of Splanchnic and Peripheral Glucose Uptake by Insulin and Hyperglycemia in Man , 1983, Diabetes.

[44]  T. Jenssen,et al.  Contribution of abnormal muscle and liver glucose metabolism to postprandial hyperglycemia in NIDDM. , 1990, Diabetes.

[45]  Claudio Cobelli,et al.  A minimal model of insulin secretion and kinetics to assess hepatic insulin extraction. , 2006, American journal of physiology. Endocrinology and metabolism.

[46]  Claudio Cobelli,et al.  Use of a novel triple-tracer approach to assess postprandial glucose metabolism. , 2003, American journal of physiology. Endocrinology and metabolism.

[47]  Use of a variable insulin infusion to assess insulin action in obesity: defects in both the kinetics and amplitude of response. , 1987, The Journal of clinical endocrinology and metabolism.

[48]  R N Bergman,et al.  Assessment of insulin sensitivity in vivo. , 1985, Endocrine reviews.

[49]  P. Chou,et al.  Relative role of insulin resistance and beta-cell dysfunction in the progression to type 2 diabetes--The Kinmen Study. , 2003, Diabetes research and clinical practice.

[50]  L. Mandarino,et al.  Dose-response characteristics for effects of insulin on production and utilization of glucose in man. , 1981, The American journal of physiology.

[51]  C Cobelli,et al.  SAAM II: Simulation, Analysis, and Modeling Software for tracer and pharmacokinetic studies. , 1998, Metabolism: clinical and experimental.

[52]  Masafumi Matsuda,et al.  beta-Cell function in subjects spanning the range from normal glucose tolerance to overt diabetes: a new analysis. , 2005, The Journal of clinical endocrinology and metabolism.

[53]  Kwang‐Won Kim,et al.  Insulin secretory dysfunction and insulin resistance in the pathogenesis of korean type 2 diabetes mellitus. , 2001, Metabolism: clinical and experimental.

[54]  A. Vaag,et al.  Insulin resistance as the major cause of impaired glucose tolerance: a self-fulfilling prophesy? , 1994, The Lancet.

[55]  L. Groop,et al.  Insulin secretion and insulin sensitivity in relation to glucose tolerance: lessons from the Botnia Study. , 2000, Diabetes.

[56]  R. Rizza,et al.  Both fasting glucose production and disappearance are abnormal in people with "mild" and "severe" type 2 diabetes. , 2004, American journal of physiology. Endocrinology and metabolism.

[57]  C Cobelli,et al.  Beta-cell function during insulin-modified intravenous glucose tolerance test successfully assessed by the C-peptide minimal model. , 1999, Metabolism: clinical and experimental.